Principal Investigator
Wendy Lee
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20231260
Clinical Trial Summary
A randomized, double-masked, placebo-controlled safety, tolerability, and efficacy study of VRDN-001, a humanized monoclonal antibody directed against the IGF-1 receptor, in participants with chronic thyroid eye disease (TED)
Phase
TBD
Funding Agency/Sponsor
Industry
Disease
Other
Contact Information
Study Contact
Marlene Perez
Phone Number
+1 (305) 4824309
Email
mcolon@miami.edu